Aspirin and clopidogrel alter core temperature and skin blood flow during heat stress

Rebecca S. Bruning, Jessica D. Dahmus, William Lawrence Kenney, Jr., Lacy Marie Alexander

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Antithrombotic therapy with oral aspirin (ASA) or clopidogrel (CLO) (Plavix®; Bristol-Myers Squibb, Bridgewater, NJ) is associated with an attenuated skin vasodilator response and a greater rate of rise in core temperature in healthy, middle-age individuals during passive heating in a water perfused suit. Purpose: The present double-blind, crossover study examined the functional consequences of 7 d of low-dose ASA (81 mg·d-1) versus CLO (75 mg·d-1) treatment in 14 healthy, middle-age (50-65 yr) men and women during passive heating in air (40 min at 30°C, 40% relative humidity) followed by exercise (60% V̇O2peak). Methods: Oral temperature (Tor) was measured in the antechamber (23.0°C ± 0.1°C) before entering a warm environmental chamber. After 40 min of rest, subjects cycled on a recumbent cycle ergometer for up to 120 min. Esophageal temperature (Tes) and laser Doppler flux were measured continuously, and the latter was normalized to maximal cutaneous vascular conductance (%CVCmax). Results: Before entry into the environmental chamber there were no differences in Tor among treatments; however, after 40 min of rest in the heat, Tes was significantly higher for ASA and CLO versus placebo (37.2°C ± 0.1°C, 37.3°C ± 0.1°C, vs 37.0°C ± 0.1°C, both P < 0.001), a difference that persisted throughout exercise (P < 0.001 vs placebo). The mean body temperature thresholds for the onset of cutaneous vasodilation were shifted to the right for both ASA and CLO during exercise (P < 0.05). Conclusion: ASA and CLO resulted in elevated core temperatures during passive heat stress and shifted the onset of peripheral thermoeffector mechanisms toward higher body temperatures during exercise heat stress.

Original languageEnglish (US)
Pages (from-to)674-682
Number of pages9
JournalMedicine and Science in Sports and Exercise
Volume45
Issue number4
DOIs
StatePublished - Jan 1 2013

Fingerprint

clopidogrel
Skin Temperature
Aspirin
Hot Temperature
Exercise
Temperature
Body Temperature
Heating
Skin
Placebos
Humidity
Vasodilator Agents
Double-Blind Method
Vasodilation
Cross-Over Studies
Blood Vessels
Lasers
Therapeutics
Air

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

@article{e683b6351c384fddb8239656311164a6,
title = "Aspirin and clopidogrel alter core temperature and skin blood flow during heat stress",
abstract = "Antithrombotic therapy with oral aspirin (ASA) or clopidogrel (CLO) (Plavix{\circledR}; Bristol-Myers Squibb, Bridgewater, NJ) is associated with an attenuated skin vasodilator response and a greater rate of rise in core temperature in healthy, middle-age individuals during passive heating in a water perfused suit. Purpose: The present double-blind, crossover study examined the functional consequences of 7 d of low-dose ASA (81 mg·d-1) versus CLO (75 mg·d-1) treatment in 14 healthy, middle-age (50-65 yr) men and women during passive heating in air (40 min at 30°C, 40{\%} relative humidity) followed by exercise (60{\%} V̇O2peak). Methods: Oral temperature (Tor) was measured in the antechamber (23.0°C ± 0.1°C) before entering a warm environmental chamber. After 40 min of rest, subjects cycled on a recumbent cycle ergometer for up to 120 min. Esophageal temperature (Tes) and laser Doppler flux were measured continuously, and the latter was normalized to maximal cutaneous vascular conductance ({\%}CVCmax). Results: Before entry into the environmental chamber there were no differences in Tor among treatments; however, after 40 min of rest in the heat, Tes was significantly higher for ASA and CLO versus placebo (37.2°C ± 0.1°C, 37.3°C ± 0.1°C, vs 37.0°C ± 0.1°C, both P < 0.001), a difference that persisted throughout exercise (P < 0.001 vs placebo). The mean body temperature thresholds for the onset of cutaneous vasodilation were shifted to the right for both ASA and CLO during exercise (P < 0.05). Conclusion: ASA and CLO resulted in elevated core temperatures during passive heat stress and shifted the onset of peripheral thermoeffector mechanisms toward higher body temperatures during exercise heat stress.",
author = "Bruning, {Rebecca S.} and Dahmus, {Jessica D.} and {Kenney, Jr.}, {William Lawrence} and Alexander, {Lacy Marie}",
year = "2013",
month = "1",
day = "1",
doi = "10.1249/MSS.0b013e31827981dc",
language = "English (US)",
volume = "45",
pages = "674--682",
journal = "Medicine and Science in Sports and Exercise",
issn = "0195-9131",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Aspirin and clopidogrel alter core temperature and skin blood flow during heat stress. / Bruning, Rebecca S.; Dahmus, Jessica D.; Kenney, Jr., William Lawrence; Alexander, Lacy Marie.

In: Medicine and Science in Sports and Exercise, Vol. 45, No. 4, 01.01.2013, p. 674-682.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Aspirin and clopidogrel alter core temperature and skin blood flow during heat stress

AU - Bruning, Rebecca S.

AU - Dahmus, Jessica D.

AU - Kenney, Jr., William Lawrence

AU - Alexander, Lacy Marie

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Antithrombotic therapy with oral aspirin (ASA) or clopidogrel (CLO) (Plavix®; Bristol-Myers Squibb, Bridgewater, NJ) is associated with an attenuated skin vasodilator response and a greater rate of rise in core temperature in healthy, middle-age individuals during passive heating in a water perfused suit. Purpose: The present double-blind, crossover study examined the functional consequences of 7 d of low-dose ASA (81 mg·d-1) versus CLO (75 mg·d-1) treatment in 14 healthy, middle-age (50-65 yr) men and women during passive heating in air (40 min at 30°C, 40% relative humidity) followed by exercise (60% V̇O2peak). Methods: Oral temperature (Tor) was measured in the antechamber (23.0°C ± 0.1°C) before entering a warm environmental chamber. After 40 min of rest, subjects cycled on a recumbent cycle ergometer for up to 120 min. Esophageal temperature (Tes) and laser Doppler flux were measured continuously, and the latter was normalized to maximal cutaneous vascular conductance (%CVCmax). Results: Before entry into the environmental chamber there were no differences in Tor among treatments; however, after 40 min of rest in the heat, Tes was significantly higher for ASA and CLO versus placebo (37.2°C ± 0.1°C, 37.3°C ± 0.1°C, vs 37.0°C ± 0.1°C, both P < 0.001), a difference that persisted throughout exercise (P < 0.001 vs placebo). The mean body temperature thresholds for the onset of cutaneous vasodilation were shifted to the right for both ASA and CLO during exercise (P < 0.05). Conclusion: ASA and CLO resulted in elevated core temperatures during passive heat stress and shifted the onset of peripheral thermoeffector mechanisms toward higher body temperatures during exercise heat stress.

AB - Antithrombotic therapy with oral aspirin (ASA) or clopidogrel (CLO) (Plavix®; Bristol-Myers Squibb, Bridgewater, NJ) is associated with an attenuated skin vasodilator response and a greater rate of rise in core temperature in healthy, middle-age individuals during passive heating in a water perfused suit. Purpose: The present double-blind, crossover study examined the functional consequences of 7 d of low-dose ASA (81 mg·d-1) versus CLO (75 mg·d-1) treatment in 14 healthy, middle-age (50-65 yr) men and women during passive heating in air (40 min at 30°C, 40% relative humidity) followed by exercise (60% V̇O2peak). Methods: Oral temperature (Tor) was measured in the antechamber (23.0°C ± 0.1°C) before entering a warm environmental chamber. After 40 min of rest, subjects cycled on a recumbent cycle ergometer for up to 120 min. Esophageal temperature (Tes) and laser Doppler flux were measured continuously, and the latter was normalized to maximal cutaneous vascular conductance (%CVCmax). Results: Before entry into the environmental chamber there were no differences in Tor among treatments; however, after 40 min of rest in the heat, Tes was significantly higher for ASA and CLO versus placebo (37.2°C ± 0.1°C, 37.3°C ± 0.1°C, vs 37.0°C ± 0.1°C, both P < 0.001), a difference that persisted throughout exercise (P < 0.001 vs placebo). The mean body temperature thresholds for the onset of cutaneous vasodilation were shifted to the right for both ASA and CLO during exercise (P < 0.05). Conclusion: ASA and CLO resulted in elevated core temperatures during passive heat stress and shifted the onset of peripheral thermoeffector mechanisms toward higher body temperatures during exercise heat stress.

UR - http://www.scopus.com/inward/record.url?scp=84878827171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878827171&partnerID=8YFLogxK

U2 - 10.1249/MSS.0b013e31827981dc

DO - 10.1249/MSS.0b013e31827981dc

M3 - Article

C2 - 23135368

AN - SCOPUS:84878827171

VL - 45

SP - 674

EP - 682

JO - Medicine and Science in Sports and Exercise

JF - Medicine and Science in Sports and Exercise

SN - 0195-9131

IS - 4

ER -